NEWS
View news from our Featured Companies.
Kiora Pharmaceuticals Reports First Quarter Results; Positive Clinical Data Driving Significant Progress Advancing Pipeline of Eye Disease Treatments
Encinitas, California--(May 9, 2023) - Kiora Pharmaceuticals (NASDAQ: KPRX) announced its first quarter 2023 results, during which time it significantly advanced its ocular drug development pipeline of clinical-stage candidates for the treatment of Retinitis...
S&W Seed Company to Report Third Quarter Fiscal Year 2023 Financial Results on Thursday, May 11, 2023
Conference call to be conducted on Thursday, May 11, 2023, at 11:00AM ET LONGMONT, Colo., May 8, 2023 -- S&W Seed Company (Nasdaq: SANW) will report financial results for its third quarter fiscal year 2023, ended March 31, 2023, on Thursday, May 11, 2023, before...
InfuSystem to Present at Sidoti Micro-Cap Virtual Conference on May 11, 2023
Investor Presentation to be held at 9:15 a.m. Eastern Time ROCHESTER HILLS, Mich. - InfuSystem Holdings, Inc. (NYSE American: INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical...
Mogo Schedules Q1 2023 Earnings Conference Call
VANCOUVER, British Columbia - Mogo Inc. (TSX:MOGO) (NASDAQ:MOGO) ("Mogo" or the "Company"), a digital payments and financial technology company, today announced it will hold a conference call and webcast to discuss its Q1 2023 financial results on Thursday, May 11,...
Aytu BioPharma to Report Third Quarter Fiscal 2023 Financial Results on May 11, 2023
ENGLEWOOD, CO / May 4, 2023 / Aytu BioPharma, Inc. (the Company or "Aytu") (NASDAQ:AYTU), a commercial stage pharmaceutical and consumer health company providing pediatric-focused prescription drugs and cost-effective consumer health solutions, will report financial...
LiqTech International to Discuss First Quarter 2023 Results on Thursday, May 11, 2023
Management to Host Conference Call on Thursday, May 11, 2023, at 9:00 a.m. ET BALLERUP, Denmark, May 4, 2023 -- LiqTech International, Inc. (NASDAQ: LIQT), a clean technology company that manufactures and markets highly specialized filtration products and systems,...
SenesTech to Report First Quarter 2023 Financial Results on Thursday, May 11, 2023
Financial results to be released after market close; Conference call to be conducted at 5:00 pm ET PHOENIX, May 4, 2023 -- SenesTech, Inc. (NASDAQ: SNES) will report financial results for its first quarter 2023, ended March 31, 2023, after the market close on...
Mogo Granted Extension to Meet Nasdaq Minimum Bid Price Deficiency
VANCOUVER, British Columbia - Mogo Inc. (NASDAQ:MOGO) (TSX:MOGO) ("Mogo" or the "Company"), one of Canada's leading financial technology companies, today announced that it received a notice (the "Extension Notice") from the Nasdaq Stock Market LLC ("Nasdaq") granting...
IRADIMED CORPORATION Announces First Quarter 2023 Financial Results
Reports record revenue of $15.5 million for the first-quarter quarter of 2023 GAAP diluted EPS of $0.27 and non-GAAP diluted EPS of $0.30 Operating income was $4.0 million and increased by 30% Announces second quarter 2023 financial guidance and increases full-year...
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2023
Conference Call Scheduled for Friday, May 12, 2023 at 9:00 AM ETPORTLAND, Maine, May 04, 2023 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically proven and...
InfuSystem Reports First Quarter 2023 Financial Results
Record Net Revenues of $30.4 million Representing 13% Growth From the Prior Year ROCHESTER HILLS, Mich. - InfuSystem Holdings, Inc. (NYSE American: INFU), ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care...
Reviva Pharmaceuticals to Present at Three Upcoming Scientific Conferences in May 2023
CUPERTINO, Calif., May 04, 2023 -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) ("Reviva" or the "Company"), a clinical-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS),...
ChromaDex to Report First Quarter 2023 Financial Results on Wednesday, May 10, 2023
LOS ANGELES - ChromaDex Corp. (NASDAQ:CDXC) ("the Company") a global bioscience company dedicated to healthy aging, announced that it will hold a conference call on Wednesday, May 10, 2023 at 4:30 p.m. ET to discuss its financial results for the first quarter, which...
Reviva Pharmaceuticals Presented Foundational Preclinical Data on Novel Serotonin-Dopamine Stabilizer Brilaroxazine at the 78th Annual SOBP and Publication in Medical Research Archives
Multifaceted activity of brilaroxazine supports potential for improvement in behavioral symptoms as well as accompanying neuroinflammation This proof-of-concept data supported the initial clinical development of brilaroxazine and reinforces the clinical profile...
Aytu BioPharma Subleases a Portion of Its Manufacturing Facility
ENGLEWOOD, CO / May 1, 2023 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (NASDAQ:AYTU), a commercial stage pharmaceutical and consumer health company providing pediatric-focused prescription drugs and cost-effective consumer health solutions, entered into an...
ZOOMD TECHNOLOGIES ENGAGES GENERATION IACP INC. TO PROVIDE MARKET MAKING SERVICES
VANCOUVER, BC, May 1, 2023 /CNW/ -- Zoomd Technologies Ltd. (TSXV: ZOMD) (OTC: ZMDTF) and its wholly-owned subsidiary Zoomd Ltd. (collectively, "Zoomd" or the "Company"), the marketing tech (MarTech) user-acquisition and engagement platform, announces that, subject to...
Kiora Pharmaceuticals Presents Encore Imaging Results of KIO-301 for Retinitis Pigmentosa at ASNR 2023 Meeting
Encinitas, California--(May 1, 2023) - Kiora Pharmaceuticals (NASDAQ: KPRX) announced today an encore presentation on KIO-301 neuroimaging results at The American Society of Neuroradiology 2023 Meeting in Chicago. The late-breaking abstract presentation titled...
Zoomd Technologies Reports Fourth Quarter and Fiscal 2022 Financial Results
Conference call will be held on April 28, 2023 at 11AM ET VANCOUVER, British Columbia, April 28, 2023 /CNW/ -- Zoomd Technologies Ltd. (TSXV: ZOMD) (OTC: ZMDTF) and its wholly-owned subsidiary Zoomd Ltd. (collectively, "Zoomd" or the "Company"), the marketing...
InfuSystem to Report First Quarter 2023 Financial Results on May 4, 2023
Investor Conference Call to be held 9:00 a.m. Eastern Time ROCHESTER HILLS, Mich. - InfuSystem Holdings, Inc. (NYSE American: INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical...
S&W Announces Transition of Betsy Horton to Board of Directors
Horton to resign as Chief Financial Officer; Company appoints agricultural industry veteran Vanessa Baughman as the Company's Interim Chief Financial Officer LONGMONT, Colo., April 27, 2023 -- S&W Seed Company (Nasdaq: SANW), a global agricultural company, today...
Kiora’s Investigational Treatment for Retinitis Pigmentosa, KIO-301, Demonstrates Visual Function Restoration in Patients Who Are Blind
Encinitas, California--(April 27, 2023) - Kiora Pharmaceuticals (NASDAQ: KPRX) presented preliminary results from an ongoing clinical trial showing its investigational drug, KIO-301, has the potential to restore light perception in patients who are blind or living...
IRADIMED CORPORATION to Hold 2023 First Quarter Financial Results Conference Call on May 4th
WINTER SPRINGS, Fla., April 27, 2023 -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2023 first quarter financial results before the market opens on Thursday, May 4th. Iradimed management will host a conference call the same...
Aytu BioPharma Announces Approval of Adzenys XR-ODT®Manufacturing Site Transfer
U.S. Food & Drug Administration Approval of Prior Approval Supplement Enables Transfer of Adzenys Production to Contract Manufacturer in 2023Upon Completion of Manufacturing Transfer of Adzenys XR-ODT and Cotempla XR-ODT, Company Expects to Improve ADHD Product...
LiqTech Enters Distribution Agreement with Silicon Filter in China for Phosphoric Acid Purification Applications
BALLERUP, Denmark and BEIJING, April 26, 2023 -- LiqTech International, Inc. (NASDAQ: LIQT), a clean technology company that manufactures and markets highly specialized filtration products and systems, and Silicon Filter, a China-based company focused on providing...
Kiora Pharmaceuticals’ KIO-201 Heals Wounds in Phase 2 Trial of Patients with Persistent Corneal Epithelial Defects
In a second presentation, Kiora shared additional positive results for its KIO-100 platform in the treatment of autoimmune uveitis.Encinitas, California--(April 26, 2023) - Kiora Pharmaceuticals (NASDAQ: KPRX) presented results of a Phase 2 clinical trial for KIO-201...